SARS-CoV-2, the virus that causes COVID-19, is more infectious than severe acute respiratory syndrome (SARS) and Middle East ...

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, ...

A virus reservoir in the body may explain why some people experience long COVID symptoms. A recent study indicates that long ...

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, ...

CoV-2 proteins in the blood of long COVID sufferers could be a key factor in their ongoing symptoms. This discovery offers new insights into the complex nature of long COVID and potentially points ...

XEC has become the second most prevalent strain in the country, according to data released by the U.S. Centers for Disease Control and Prevention ( CDC ), representing more than 1 in 10 cases. But ...

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an ...

SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. The discovery may ...

Once dismissed as a conspiracy theory, the idea that Covid-19 originated in a virology lab in Wuhan now has many adherents ...

Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social vulnerability index (SVI) and ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...